SMAD3 and type 2 diabetes mellitus: In line with this, TGFβ/SMAD3 signalling regulates insulin transcription in pancreatic islet β-cells, whereas SMAD3 deficiency in mice protects against insulin resistance and type 2 diabetes during high-fat-diet-induced obesity [59,60].